Theravance Biopharma, Inc.
TBPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583107
In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 2 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Theravance Biopharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +12 vs. Q1 2024
- Shares held
- 47.1M
- −763.6K (−1.6%) vs. Q1 2024
- Total value
- $399.5M
- −$30.0M (−7.0%) vs. Q1 2024
- New holders
- 25
- 43 more added
- Sold out
- 13
- 46 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 179 | $817.5M |
| Q1 2026 | 173 | $814.2M |
| Q4 2025 | 169 | $927.2M |
| Q3 2025 | 161 | $706.3M |
| Q2 2025 | 135 | $512.2M |
| Q1 2025 | 132 | $400.9M |
| Q4 2024 | 128 | $422.4M |
| Q3 2024 | 119 | $368.9M |
| Q2 2024 | 132 | $399.5M |
| Q1 2024 | 121 | $430.6M |
| Q4 2023 | 118 | $548.7M |
| Q3 2023 | 115 | $438.5M |
| Q2 2023 | 119 | $546.3M |
| Q1 2023 | 114 | $652.6M |
| Q4 2022 | 119 | $696.1M |
| Q3 2022 | 123 | $649.8M |
| Q2 2022 | 113 | $582.0M |
| Q1 2022 | 121 | $602.5M |
| Q4 2021 | 116 | $655.6M |
| Q3 2021 | 119 | $448.8M |
| Q2 2021 | 109 | $883.1M |
| Q1 2021 | 107 | $1.09B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 161,699 | $1.37M | 0.00% | +128,241+383.3% | Added |
| SG Americas Securities, LLC | 162,388 | $1.38M | 0.01% | −47,178−22.5% | Reduced |
| Bank of Montreal | 160,138 | $1.41M | 0.00% | +93,702+141.0% | Added |
| Tudor Investment Corp Et Al | 193,768 | $1.64M | 0.02% | +16,156+9.1% | Added |
| Gsa Capital Partners LLP | 204,089 | $1.73M | 0.12% | +204,089 | New |
| Macquarie Group Ltd | 209,492 | $1.78M | 0.00% | +709+0.3% | Added |
| Citadel Advisors LLC | 244,014 | $2.07M | 0.00% | +128,206+110.7% | Added |
| JPMorgan Chase & Co | 259,259 | $2.20M | 0.00% | +228,396+740.0% | Added |
| Charles Schwab Investment Management Inc | 291,266 | $2.47M | 0.00% | −19,235−6.2% | Reduced |
| Marshall Wace, LLP | 297,499 | $2.52M | 0.00% | +135,426+83.6% | Added |
| Dimensional Fund Advisors LP | 330,181 | $2.80M | 0.00% | +91,679+38.4% | Added |
| Goldman Sachs Group Inc | 333,551 | $2.83M | 0.00% | +110,801+49.7% | Added |
| Nuveen Asset Management, LLC | 342,715 | $2.91M | 0.00% | +182,897+114.4% | Added |
| Wellington Management Group LLP | 350,587 | $2.97M | 0.00% | +19,625+5.9% | Added |
| Morgan Stanley | 458,923 | $3.89M | 0.00% | +39,810+9.5% | Added |
| Northern Trust Corp | 464,967 | $3.94M | 0.00% | −23,785−4.9% | Reduced |
| Bank of America Corp | 476,169 | $4.04M | 0.00% | −44,327−8.5% | Reduced |
| Jacobs Levy Equity Management, Inc | 586,614 | $4.97M | 0.02% | +28,643+5.1% | Added |
| D. E. Shaw & Co., Inc. | 758,080 | $6.43M | 0.01% | −23,505−3.0% | Reduced |
| Geode Capital Management, LLC | 857,386 | $7.27M | 0.00% | −110,066−11.4% | Reduced |
| Pictet Asset Management Holding SA | 878,655 | $7.45M | 0.01% | −1,164,956−57.0% | Reduced |
| Camber Capital Management LP | 1,000,000 | $8.48M | 0.33% | 00.0% | Unchanged |
| Oasis Management Co Ltd. | 1,157,965 | $9.82M | 3.29% | 00.0% | Unchanged |
| State Street Corp | 1,267,375 | $10.7M | 0.00% | −101,406−7.4% | Reduced |
| Park West Asset Management LLC | 1,700,000 | $14.4M | 1.13% | +542,837+46.9% | Added |
| Vanguard Group Inc | 2,002,179 | $17.0M | 0.00% | −683,674−25.5% | Reduced |
| Newtyn Management, LLC | 2,124,703 | $18.0M | 3.38% | +480,773+29.2% | Added |
| Irenic Capital Management LP | 2,760,948 | $23.4M | 5.68% | 00.0% | Unchanged |
| BlackRock Inc. | 3,780,160 | $32.1M | 0.00% | −428,177−10.2% | Reduced |
| Baupost Group LLCSuperinvestorBaupost Group | 4,200,021 | $35.6M | 0.98% | −2,394,105−36.3% | Reduced |
| Weiss Asset Management LP | 7,457,060 | $63.2M | 3.04% | 00.0% | Unchanged |
| Madison Avenue Partners, LP | 8,511,350 | $72.2M | 9.12% | +1,499,124+21.4% | Added |
| Jump Financial, LLC | 0 | $0 | 0.00% | −43,447−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −40,166−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −23,942−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −14,888−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −14,708−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,219−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −11,576−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −11,410−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −10,101−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −5,834−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,773−100.0% | Sold out |
| Newbridge Financial Services Group, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |